KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Arbutus Biopharma (ABUS) Preferred Shares Issued (2017 - 2018)

Arbutus Biopharma's Preferred Shares Issued history spans 3 years, with the latest figure at -$66.3 million for Q4 2019.

  • For Q4 2019, Preferred Shares Issued changed N/A year-over-year to -$66.3 million; the TTM value through Sep 2019 reached $115.1 million, changed N/A, while the annual FY2018 figure was $66.3 million, 35.6% up from the prior year.
  • Preferred Shares Issued for Q4 2019 was -$66.3 million at Arbutus Biopharma, down from $66.3 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $66.3 million in Q1 2018 and bottomed at -$66.3 million in Q4 2019.
  • The 3-year median for Preferred Shares Issued is $48.9 million (2017), against an average of $16.3 million.